AC Immune SA (ACIU)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | PHARMACEUTICAL PREPARATIONS |
CEO: | Andrea Pfeifer |
Employees: | 140 |
Web site: | acimmune.com |
EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, V8, 00000
41 21 345 91 21
|
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
AC Immune SA discovers, designs, and develops medicines and diagnostic products. The company is developing Crenezumab, a humanized, conformation-specific monoclonal antibody, which is in Phase II clinical prevention trial for the treatment of Alzheimer's disease. It is also developing ACI-24, an anti-Abeta vaccine candidate, as well as completed Phase Ib clinical study for Down syndrome. Further, it has discovery and preclinical stage molecules targeting range of neurodegenerative diseases.
Please log in first to see chart